Paragonix Technologies markets organ transportation devices that safeguard organs during the journey between donor and recipient patients.

Their devices incorporate clinically proven and medically trusted cold preservation techniques in a novel suspension system to provide unprecedented physical and thermal protection. Paragonix SherpaPak™ CTS is the only commercially available FDA cleared and CE marked transport device for heart transportation. Paragonix is also developing transport devices for the lung and kidneys designed to improve donor organ quality and extending donor organ transport time.

  • SherpaPak

    A cold storage device intended to standardize and control donor heart preservation and transport.

    See Product